Christopher Bunick, MD, PhD
Associate Professor of Dermatology, Program in Translational Biomedicine, Institute for Global Health, Yale School of Medicine, New Haven, CT
Northeast/New_England, CT
Disclosure
Advisory Board: AbbVie, AbSci, Almirall, Alumis, Amgen, Apogee, Arcutis, Botanix, Castle Biosciences, Dermavant, Disc Medicine, Eli Lilly, EPI Health/Novan, Galderma, Highlight Therapeutics, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Priovant, Regeneron, Sanofi, Sun Pharma, Takeda, Triveni, UCB, and Veradermics
Grant/Research Support: Almirall, Ortho Dermatologics, Sun Pharma
Consultant: AbbVie, AbSci, Almirall, Alumis, Amgen, Apogee, Arcutis, Botanix, Castle Biosciences, Connect BioPharma, Daiichi Sankyo, Dermavant, Disc Medicine, Eli Lilly, EPI Health/Novan, Galderma, Highlight Therapeutics, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Palvella, Pfizer, Priovant, Regeneron, Sanofi, South Beach Symposium, Sun Pharma, Takeda, Timber, Teladoc, Triveni, UCB, and Veradermics